Sean N. Prater

1.2k total citations
19 papers, 875 citations indexed

About

Sean N. Prater is a scholar working on Physiology, Rheumatology and Organic Chemistry. According to data from OpenAlex, Sean N. Prater has authored 19 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 8 papers in Rheumatology and 7 papers in Organic Chemistry. Recurrent topics in Sean N. Prater's work include Lysosomal Storage Disorders Research (17 papers), Glycogen Storage Diseases and Myoclonus (8 papers) and Carbohydrate Chemistry and Synthesis (7 papers). Sean N. Prater is often cited by papers focused on Lysosomal Storage Disorders Research (17 papers), Glycogen Storage Diseases and Myoclonus (8 papers) and Carbohydrate Chemistry and Synthesis (7 papers). Sean N. Prater collaborates with scholars based in United States, France and United Kingdom. Sean N. Prater's co-authors include Priya S. Kishnani, Suhrad G. Banugaria, Amy S. Rosenberg, Joyce A. Kobori, Roger L. Ladda, Yuan-Tsong Chen, Richard S. Finkel, Stephanie DeArmey, Raymond Wang and Sarah P. Young and has published in prestigious journals such as PLoS ONE, Journal of Virology and Genetics in Medicine.

In The Last Decade

Sean N. Prater

19 papers receiving 854 citations

Peers

Countries citing papers authored by Sean N. Prater

Since Specialization

Citations

This map shows the geographic impact of Sean N. Prater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean N. Prater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean N. Prater more than expected).

Fields of papers citing papers by Sean N. Prater

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean N. Prater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean N. Prater. The network helps show where Sean N. Prater may publish in the future.

Co-authorship network of co-authors of Sean N. Prater

This figure shows the co-authorship network connecting the top 25 collaborators of Sean N. Prater. A scholar is included among the top collaborators of Sean N. Prater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean N. Prater. Sean N. Prater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy 2017 ·Molecular Genetics and Metabolism ·(unknown), Lisa D. Hobson‐Webb, Zoheb B. Kazi, Sean N. Prater, Suhrad G. Banugaria, Stephanie Austin, Raymond Wang, David S. Enterline, Donald P. Frush, Priya S. Kishnani	45
2	Durable and sustained immune tolerance to ERT in Pompe disease with entrenched immune responses 2016 ·JCI Insight ·Zoheb B. Kazi, Sean N. Prater, Joyce A. Kobori, David Viskochil, Carrie Bailey, (unknown), David W. Stockton, (unknown), Amy S. Rosenberg, Priya S. Kishnani	27
3	Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy 2016 ·Molecular Genetics and Metabolism ·Stephanie Austin, Lisa D. Hobson‐Webb, Sean N. Prater, Suhrad G. Banugaria, Raymond Wang, David S. Enterline, Donald P. Frush, Priya S. Kishnani	1
4	CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy 2015 ·Genetics in Medicine ·Kathryn L. Berrier, Zoheb B. Kazi, Sean N. Prater, Deeksha Bali, Jennifer Goldstein, (unknown), Catherine Rehder, Eleanor G. Botha, Carolyn Ellaway, Kaustuv Bhattacharya, Anna Tylki‐Szymańska, Nesrin Karabul, (unknown), Priya S. Kishnani	49
5	Consideration of increased dosing of alglucosidase alfa to achieve improved clinical outcomes in infantile Pompe disease 2015 ·Molecular Genetics and Metabolism ·Sean N. Prater, Kathryn L. Berrier, Sarah P. Young, Katherine Kim, Barbara K. Burton, Priya S. Kishnani	1
6	The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients 2014 ·Acta Neuropathologica Communications ·Erin Feeney, Stephanie Austin, Yin‐Hsiu Chien, Hanna Mandel, Benedikt Schoser, Sean N. Prater, Wuh‐Liang Hwu, Evelyn Ralston, Priya S. Kishnani, Nina Raben	51
7	Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease 2014 ·Molecular Genetics and Metabolism Reports ·Baodong Sun, Suhrad G. Banugaria, Sean N. Prater, Trusha Patel, (unknown), D J Ringler, Antonin de Fougerolles, Amy S. Rosenberg, Herman Waldmann, Priya S. Kishnani	11
8	Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT 2013 ·PLoS ONE ·Suhrad G. Banugaria, Sean N. Prater, Trusha Patel, Stephanie DeArmey, (unknown), Kathryn L. Berrier, Deeksha Bali, Catherine Rehder, Julian Raiman, (unknown), François Labarthe, Joel Charrow, Paul Harmatz, Pranesh Chakraborty, Amy S. Rosenberg, Priya S. Kishnani	87
9	Approach to management of cross-reactive immunologic material (CRIM)-negative infantile pompe patients treated with ERT: Role of immune modulation in changing the natural history 2013 ·Molecular Genetics and Metabolism ·Suhrad G. Banugaria, Sean N. Prater, Trusha Patel, Stephanie DeArmey, (unknown), Julian Raiman, Raymond Wang, François Labarthe, (unknown), Paul Harmatz, (unknown), (unknown)	1
10	Structures of the Compact Helical Core Domains of Feline Calicivirus and Murine Norovirus VPg Proteins 2013 ·Journal of Virology ·Eoin Leen, (unknown), James R. Birtley, P. J. Simpson, (unknown), Yasmin Chaudhry, Stanislav V. Sosnovtsev, Kim Y. Green, Sean N. Prater, Michael Tong, Joanna C. Young, (unknown), Jan Marchant, Lisa O. Roberts, C. Cheng Kao, Stephen Matthews, Ian Goodfellow, Stephen Curry	34
11	Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy 2013 ·Orphanet Journal of Rare Diseases ·Sean N. Prater, Trusha Patel, Anne F. Buckley, Hanna Mandel, (unknown), Suhrad G. Banugaria, Erin Feeney, Nina Raben, Priya S. Kishnani	57
12	Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease 2012 ·Genetics in Medicine ·Suhrad G. Banugaria, Sean N. Prater, Judeth K. McGann, Jonathan Feldman, (unknown), Carrie Bailey, (unknown), Robert L. Conway, David Viskochil, Joyce A. Kobori, Amy S. Rosenberg, Priya S. Kishnani	70
13	Autopsy findings in late-onset Pompe disease: A case report and systematic review of the literature 2012 ·Molecular Genetics and Metabolism ·Lisa D. Hobson‐Webb, Alan D. Proia, Beth L. Thurberg, Suhrad G. Banugaria, Sean N. Prater, Priya S. Kishnani	67
14	The use of non-depleting anti-CD4 monoclonal antibody for immune tolerance induction in Pompe disease 2012 ·Molecular Genetics and Metabolism ·Suhrad G. Banugaria, (unknown), Sean N. Prater, Santasabuj Das, (unknown), D J Ringler, Antonin de Fougerolles, Dwight D. Koeberl, Deeksha Bali, Boyang Sun, Herman Waldmann, Priya S. Kishnani	1
15	Long Term Outcome and Clinical Experience on Immune Tolerance Induction Therapies in Infantile Pompe Disease 2012 ·Molecular Genetics and Metabolism ·Suhrad G. Banugaria, Sean N. Prater, Deeksha Bali, Catherine Rehder, Amy S. Rosenberg, Priya S. Kishnani	1
16	The emerging phenotype of long-term survivors with infantile Pompe disease 2012 ·Genetics in Medicine ·Sean N. Prater, Suhrad G. Banugaria, Stephanie DeArmey, Eleanor G. Botha, (unknown), Laura E. Case, Harrison N. Jones, Chanika Phornphutkul, Raymond Wang, Sarah P. Young, Priya S. Kishnani	143
17	Atypical immunologic response in a patient with CRIM-negative Pompe disease 2011 ·Molecular Genetics and Metabolism ·Mary‐Alice Abbott, Sean N. Prater, Suhrad G. Banugaria, Susan Richards, Sarah P. Young, Amy S. Rosenberg, Priya S. Kishnani	24
18	The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease 2011 ·Genetics in Medicine ·Suhrad G. Banugaria, Sean N. Prater, (unknown), Joyce A. Kobori, Richard S. Finkel, Roger L. Ladda, Yuan-Tsong Chen, Amy S. Rosenberg, Priya S. Kishnani	204
19	The clinical phenotype of Long-term infantile Pompe disease survivors 2011 ·Molecular Genetics and Metabolism ·Sean N. Prater, Suhrad G. Banugaria, Joanne Mackey, (unknown), Laura E. Case, Stephanie DeArmey, Priya S. Kishnani	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact